People: Cara Therapeutics Inc (CARA.OQ)
17 Aug 2018
Dr. Michael E. Lewis is the Chief Scientific Advisor at Cara Therapeutics, Inc. Previously, he has co-founded Cephalon, Inc. and served as Director of Pharmacology and Senior Director of Scientific Affairs. He also co-founded and served as Chief Scientific Advisor to Adolor Corporation and also participated on their analgesics development team and assisted in pre-initial public offering (IPO) financing and corporate partnering presentations. He was co-founded Arena Pharmaceuticals, and served as a pre-IPO Director and Chief Scientific Advisor to Arena. He is a Director of PolyMedix, Inc., a privately held biotechnology company that is developing antimicrobial agents based on a novel computational chemistry platform.
|Total Annual Compensation,||--|
|Restricted Stock Award,||--|
|Long-Term Incentive Plans,||--|
|Fiscal Year Total,||--|